ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2026
Feasibility and safety of same-day discharge after paediatric vagus nerve stimulator implantation for medically intractable epilepsy: a retrospective safety analysis.
Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveVagal nerve stimulation (VNS) is an established adjunctive treatment for children with medically intractable epilepsy. It is common practice to admit these children overnight for observation due to concern of airway compromise and other medical complications. We wanted to determine the safety of vagal nerve stimulator insertion in the immediate peri-operative period to determine if same-day discharge is feasible and safe in children.
methodsWe conducted a retrospective review of all paediatric patients (age less than 19 years of age) who underwent vagal nerve stimulator (VNS) implantation at our institution between January 2002 and December 2022.
resultsIn total, 197 patients were included in the analysis. Mean age at surgery was 11.1 years (SD 4.1). Median length of stay was 1 day (IQR 1-1); 21 children (10.7%) were discharged the same day. There were no intraoperative complications. No child (0%) had an immediate postoperative surgical complication. Three children had postoperative medical complications (1.5%), all of which occurred in the first hour after surgery. Developmental delay was present in 95% of documented cases.
conclusionsThese findings support the safety of same-day discharge in appropriately selected patients, with structured criteria and parental guidance.
Indexed as
Identifiers
42611080What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.